N/A N=280 EDWARDS INTUITY Elite Valve System
Aortic Valve Disease · Aortic Stenosis
Primary: Subject's Average Time Spent on Cardiopulmonary Cross Clamp — 49.9; 65.2; 51.9 minutes
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=15 [18F] Flourothymidine (FLT) PET/CT Imaging for Gynecologic Cancers
Gynecologic Cancer
Primary: Patients With Changes in Bone Marrow Assessed Through Images — 0; 4 Participants
Phase 2 N=59 Lenalidomide Therapy After Chemotherapy & Stem Cell Transplant in Treating Chemotherapy Resistan Non-Hodgkin Lymphoma
Anaplastic Large Cell Lymphoma, ALK-Negative · Recurrent Anaplastic Large Cell Lymphoma · Recurrent Mantle Cell Lymphoma
Primary: Maximum Tolerated Dose of Lenalidomide (Phase I) — 10 milligrams PO daily
Phase 4 N=48 Open-Labeled PK-PD Studies of Metoprolol ER
Blood Pressure
Primary: Area Under the Plasma Concentration Versus Time Curve (AUC) — 645.5; 633.0; 654.0; 1584.4 ng.hr/ml — p=0.3
Phase 1 N=91 Pharmacokinetics and Safety Study of BI 695502 in Healthy Subjects
Healthy
Primary: Area Under the Concentration-time Curve of the Analyte in Plasma Over the Time Interval From 0 Extrapolated to Infinity (AUC0-∞). — 7013.010; 7261.119; 7649.491…
N/A N=21 THA Kinematics and Sound for Subjects for Normal, Diseased and Implanted Hips
Hip Injuries
Primary: Magnitude of Hip Separation During Primary Heel Strike — -0.591; 0.096; 0.558 mm
Phase 3 N=861 Study to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Axitinib Versus Sunitinib Monotherapy in Participants With Renal Cell Carcinoma (MK-3475-426/KEYNOTE-426)
Renal Cell Carcinoma
Primary: Progression-Free Survival (PFS) Per Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST 1.1) as Assessed by Blinded Independent Central Imaging Review…
Phase 2 N=45 Cabozantinib Plus Docetaxel and Prednisone for Advanced Prostate Cancer
Prostatic Neoplasms
Primary: Progression Free Survival (PFS) of Cabozantinib + Docetaxel + Prednisone Compared to Docetaxel + Prednisone Alone — 8; 13; 6; 10 months
Phase 2 N=114 Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases
Cancer
Primary: Cohort 1 - NaF PET/CT vs 99mTc-MDP Bone Scintigraphy — 10; 0; 0 Participants
Phase 1 N=290 A Study to Test the Safety and Antibody Response of V212 in Healthy Adults (V212-004)(COMPLETED)
Herpes Zoster
Primary: Part 1: Geometric Mean Fold Rise of the Varicella-Zoster Virus (VZV)-Specific Immune Responses Measured by Glycoprotein Enzyme-Linked Immunosorbent Assay in…
Phase 2 N=110 Extension Trial Assessing the Safety and Efficacy of BI 655066/ABBV-066/Risankizumab in Patients With Moderate to Severe Chronic Plaque Psoriasis
Psoriasis
Primary: Number of Participants With Treatment-Emergent Adverse Events (TEAEs) — 67; 18 participants
N/A N=520 Study of Lung Cancer in Appalachian Kentucky: The Role of Environmental Carcinogens
Lung Cancer
Primary: Rate of Moderate to High Arsenic Level in Cases and Controls — 0.04; 0.04 mcg/dL
Phase 1 N=15 Evaluation of the Efficacy of an Autologous Microbiome Transplant in Adult Atopic Dermatitis Patients
Atopic Dermatitis Eczema
Primary: Relative Abundance of Staphylococcus Aureus Compared to Baseline — 0.106; 12.9 Relative abundance of S. aureus
N/A N=78 Multicentre Observational Study on the Wound Pain Relief Properties of ORTODERMINA®
Wound Healing Disorder
Primary: Change of Pain Relief From Baseline to the End of Treatment Using the 5-point Visual Rating Scale (VRS) — 3; 23; 28; 20 Participants
N/A N=40 Heart Failure Medication Adherence
Heart Failure
Primary: Adherence to Medication — 2; 3 Participants